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Carreras1☯, Marc Suñé-Pou1☯, Isaac Nofrerias-Roig1☯, Encarna Garcı́a-Montoya1,2☯
1 Pharmacy and Pharmaceutical Technology, and Physical Chemistry Department, Universitat de Barcelona,
Barcelona, Spain, 2 IDIBELL-UB Research Group, Pharmacotherapy, Pharmacogenomics and
Pharmaceutical Technology, L’Hospitalet de Llobregat, Barcelona, Spain, 3 Anesthesiology Service of
Viladecans Hospital, Viladecans, Barcelona, Spain, 4 IDIBELL-UB Research Group, Patologı́a del Tubo
Digestivo, L’Hospitalet de Llobregat, Barcelona, Spain
☯ These authors contributed equally to this work.
¤ Current address: Pharmacy and Pharmaceutical Technology, and Physical Chemistry Department, Faculty
of Pharmacy and Food Sciences, Campus Diagonal, Barcelona, Spain
* perezlo@ub.edu
Abstract
The Semi-solid Control Diagram (SSCD) is a new tool designed for the study of different
excipients and different semi-solid dosage forms. It can be used to review and evaluate dif-
ferent formulations and/or batches and facilitate the selection of one of them that will present
the most suitable galenic characteristics for topical application. It is also useful to track sta-
bility studies by comparing the diagrams, which allows to measure the impact of subjecting
the formulation to different conditions and times to be examined. In this study, the Semi-
solid Control Diagram (SSCD) is used as an instrument for studying and evaluating semi-
solid pharmaceutical dosage forms, by comparing several different semisolid preparations
(lipogels). With these results, the tool is validated and the best formulation has been discrim-
inated from the others.
Introduction
There are a large number of semisolid preparations, corresponding to different pharmaceutical
dosage forms differentiating each other by their consistency and rheological characters. These
forms are normally presented in the form of creams, gels, emulsions, ointments or pastes [1].
Water in oil (W/O) creams are lipophilic emulsions in which the external hydrophobic
phase is a gel (hydrocarbon gel, oleogel or lipogel). This provides the formulation its good
spreading properties [2].
They contain one or more active ingredients dissolved or uniformly dispersed in a suitable
base and any suitable excipients such as emulsifiers, viscosity increasing agents, antimicrobials
agents, antioxidants or stabilizing agents [3].
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Some of the parameters that are usually studied to evaluate the quality of a semisolid formu-
lation are Organoleptic properties, Viscosity. Extensibility, and Centrifugation [4][5][6]. These
parameters are usually considered individually to establish the final quality of the product.
The new design, Semi-solid Control Diagram (SSCD), is a new proposed tool that has been
designed for our lab team for reviewing and evaluating the quality of different semi-solid dos-
age forms, first determining the common parameters [4] that provide us information to define
the quality of a semisolid formulation and secondly combining them to obtain an index of
quality which helps the formulator to discriminate the best formulation.
It enables a standardized comparison between several references and/or batches to facilitate
the selection of a formulation that will present the most suitable galenic characteristics for topi-
cal application.
This tool has been designed using the experience previously gained from applying the
SeDeM system to evaluate the suitability for direct compression of active ingredients or excipi-
ents in powder form [7], to control batch powder formulation and preformulation of drug
products [8], to develop direct compression tablet formulations [9][10][11][12], to define a
classification of directly compressible excipients [13] and to develop Oral Dispersable tablets
[14][15], modified-release tablets and determine the design space of the formula [16].
This tool could be broadly useful for formulation studies since it allows a comparison of the
effect of the addition of excipients on the formulation or, for example, the comparative studies
of the same excipient from different suppliers to be performed.
Another application for this tool is to evaluate and track stability studies of semi-solid for-
mulations by comparing the diagrams, which allows measure the impact of subjecting the for-
mulation to different conditions and times to be examined.
In this study, the Semi-solid Control Diagram is a new proposed tool based on previous
studies in solid dosage forms. It is used as an instrument for studying and evaluating semi-
solid pharmaceutical dosage forms, by comparing several different lipogels and evaluating a
number of previously selected parameters, resulting in a simple and rapid method for charac-
terizing and determining which profile is most suitable for achieving a good stability. This tool
can also be used in the development of pharmaceutical dosage forms in hospitals, where no
pharmaceutical design is done; however, a high quality of the drug products is required to be
administrated to the patients. This test could be used as a quality control test for small batches
prepared in hospitals.
As a consequence, this tool could be used to save time on the pharmaceutical development.
Materials andmethods
The active substance under study is an anti-inflammatory API (Active Pharmaceutical Ingredi-
ent) suitable for topical use.
The excipients that have been used for the study are Colloidal Silicon Dioxide, (Aerosil1
200, Fagron, Spain), Medium-chain Triglycerides (Fagron, Spain), Butylated Hydroxytoluene
(Fagron, Spain) and Polysorbate 80 (Tween1 80, Fagron, Spain).
Product characterization using the Semi-solid Control Diagram (SSCD)
The Semi-solid Control Diagram (SSCD) is based on the experimental study and quantitative
determination of the characterization parameters of semisolid formulations, being the main
objective, the determination of the adequacy of the formula respect to its physical quality. The
main contribution of the method is that the study of these parameters individually provide a
very partial information of the system, however studying them together we can get a prediction
most accurate about the quality of the product.
Semi-solid Control Diagram (SSCD)
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The new design for semisolid products is based on converting the experimental values
obtained from the galenic tests performed on the developed formulations into radius values,
using validated formulas that yield a normalized diagram.
In order to verify the control and characterization of the semisolid products, the radius of
the Semi-solid Control Diagram (SSCD) for each parameter are determined.






The first three parameters define the physical and technological properties of the semisolid
products.
Water activity indicates the free or fixed water content of the semisolid products that is able
to react and that may affect the properties or the stability of the pharmaceutical dosage form or
the active principle it contains.
Centrifugation tests the robustness of the semisolid products and the stability of the phar-
maceutical dosage form, evidenced by the absence of phase separation or fluidization under
conditions of mechanical stress.
The parameters will be obtained in accordance with the described methodology and will be
converted to diagram radius by applying the equations proposed.
In summary, by using these experimental physical tests we are able to establish validated
measures that determine the quality of the formulated product and allow us to compare the
different semisolid products references in order to determine which formulation will present
the best results, keeping in mind its intended use for topical applications.
Parameters of Semi-solid Control Diagram (SSCD)
The tool SSCD consists of 5 parameters, each parameter can be divided into others. These
components are described in the following sections.
Organoleptic properties (Corg.). In this case it has been divided into 5 attributes mea-
sured by 5 qualitative tests, and it has been considered that all have the same weight in the
final radius of the parameter (1/5), because none was considered more prevalent over the rest
(based on practical experience in our laboratory).
In the absence of a quantifiable value of each qualitative test, the assignment of a value
between 0 and 2 has been directly established in order to contribute to obtaining the radius
final value of the organoleptic characteristics properties, and to facilitate the quantification of
this radius.
Visual inspection of the sample and overall appearance is performed by placing a sample
amount on a glass plate. The radius final value for organoleptic properties parameter is deter-
mined by adding together the experimental values (eV) of each of the five following properties:
homogeneity, color, flow, absence of air and texture.
• Homogeneity (for the sample on the glass plate): limit value (eV) = 2
The criteria for maximum homogeneity (2) is no physical discontinuities (oil, water) or no
clumps visible in the sample with the naked eye and under a microscope.
If small discontinuities appear (only visible under a microscope, not with the naked eye), a
Semi-solid Control Diagram (SSCD)
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value of 1 is assigned.
If some discontinuities are visible with the naked eye, a value of 0 is assigned.
• Color: limit value (eV) = 2
The color is checked with the naked eye.
If color is uniform throughout the sample: 2.
If there are non-uniform parts, but they are almost imperceptible: 1.
If different shades of color are visible: 0.
• Flow through a tube or cannula: limit value (eV) = 2
The sample’s flow through a cannula with a diameter of 4.80 mm using manual force is stud-
ied and its dispersion is observed.
If it passes smoothly: 2.
If it flows with some difficulty and force is required: 1.
If it does not flow or excessive force is required: 0.
• Absence of air: limit value (eV) = 2
The absence of air is checked with the naked eye.
If there are absence of air with the naked eye and under a microscope: 2.
If there are presence of air (only visible under a microscope, not with the naked eye): 1.
If there are presence of air with the naked eye: 0.
• Texture (on glass): limit value (eV) = 2
If the texture is as expected and it can be spread properly: 2.
If the texture is not as expected and it is difficult to spread: 0.
The value of the radius is calculated by adding together the organoleptic valuations with the
following formula:











So the maximum value of the radio will be 10 and the minimum value 0.
Determination of viscosity (ŋ). A Brookfield CAP2000 (AMETEK, USA) cone and plate
viscometer is used.
A sample amount equivalent to a medium-size droplet is placed in the centre of the
viscometer.
The parameters used for the determination are:
• Spindle: 0,4 (24 mm of diameter)
• Temperature: 25 ˚C
• Hold time: 12 s
• Speed: 400 rpm
• Run time: 12 s
The value of the radius is obtained by applying the following formulas for which, based
on experience and on the type of semisolid dosage form established as target, range limits
included in the Table 1, can be set to calculate the radius of the developped formulation.
Determination of extensibility (ε). The SUÑÉ ARBUSSÀ / DEL POZO OJEDA strain
gauge is used (Fig 1) [17] [18].
The sample is placed on the strain gauge orifice with a higher of 3 mm, making sure it is
full and level. Next, it is covered with a lid and a 100 g weight is placed on it for 1 minute.
Semi-solid Control Diagram (SSCD)
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As a result of the pressure, the samples extend under the lid in a substantially circular way,
so that by measuring two of its perpendicular diameters the average value of the diameter of
the theoretical circle can be known and, from this, the surface occupied by the sample under
the action of the 100 g weight.
Table 1. Types of gel in function of the viscosity.
Type of gel Limits
(reference viscosity v1)
Formula





a; ν1 = 1000





a; ν1 = 10000





a; ν1 = 100000
a ν1 = reference viscosity (in mPas); ν2 = problem viscosity obtained (in mPas)
Note: The limits established for the viscosity will be determined by the type of semisolid dosage form studied or
desired. A medium viscosity gel is the target set for the lipogel and in this case the formula of the second line should
be applied to calculate the radius. In this case the target about viscosity (v1) will be 10000 mPas. If the objective is to
obtain a paste semisolid form with high viscosity, in this case the formula of the third line should be applied, and the
target v1 should be 100000 mPas.
https://doi.org/10.1371/journal.pone.0201643.t001
Fig 1. Suñé Arbussà / del Pozo Ojeda strain gauge used to calculate the extensibility.
https://doi.org/10.1371/journal.pone.0201643.g001
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The diameter obtained is measured using a caliper (Fig 2) and 3 measurements are made
and the mean value is calculated. Using this value as the basis, the area of the circle is calculated
(S = πr2).
The value of the radius is calculated by applying the following formula:






with ε1 being between 100 (poor extensibility, target required for pastes or ointment semisolid
dosage forms) and 1000 mm2 (high extensibility, required for fluid semisolid dosage form)
and where: ε1 = reference viscosity; ε2 = problem viscosity. In the studied case, it is required a
high extensibility as a target of quality, so, If ε2>1000 mm2, the value of the radius = 10 and if
ε2<100 mm2, the value of the radius = 0.
Determination of water activity (aw). Water activity describes the thermodynamic
energy status of the water in a system. Though not scientifically correct, it may help to picture
water activity as the amount of “available” water in a system. It is not a measure of how much
water is present in a product, but is an indicator of how much the water in the product resem-
bles and behaves like pure water. Water activity values range from 0 (bone dry) to 1.0 (pure
water). As water activity decreases, the water in a product decreases in energy and is less
Fig 2. Suñé Arbussà / del Pozo Ojeda strain gauge with the sample.
https://doi.org/10.1371/journal.pone.0201643.g002
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“available” for microbial growth, for chemical reactivity, for moisture migration, and to act as
a solvent.
The water activity (aw) corresponds to the ratio of the partial water-vapor pressure in equi-
librium with the product analyzed to the water-vapor saturation pressure in equilibrium with






pF(T): is the partial water-vapor pressure in equilibrium with the product analyzed at the
temperature T (kept constant during measurement);
PS(T): is the water-vapor saturation pressure in equilibrium with pure water at the same
temperature T.
Water activity is therefore a dimensionless quantity between 0, which corresponds to a
completely anhydrous sample, and 1, which corresponds to pure salt-free water.
The relative humidity at the equilibrium point is 100 times the water activity.
In order to determine aw, the dish device (plastic container) is filled halfway with the sample
and placed in the lower chamber. The AQUALAB 4TEV (DECAGON DEVICES, USA) (Fig
3) water activity meter is used to measure the water activity.
The value of the radius is calculated using the following formula:
r ¼ 10  ð10 awÞ ð4Þ
Centrifugation (Cf). The P SELECTAMEDITRONIC (JP SELECTA S.A, SPAIN) centri-
fuge is used with a rotor code 7001082 and with a tube diameter of 25 mm.
Approximately 5 g of sample is weighed in a centrifuge tube at a speed of 5000 rpm for 15
minutes. If phase separation occurs, the test is repeated, reducing the speed to 1000 rpm. The
radius for this parameter is determined using the values obtained after centrifugation, in
Table 2 could be found the assigned values.
Calculation of the index for the model. As a summary, the list of sub-parameters in
order to obtain the value of the five main parameters are shown in Table 3 and the formula to
correct the experimental results into the standardized radii is shown in the last column.
Finally, the Semi-solid Control Diagram (SSCD) also calculates the following three indexes,
which will give easily an idea of the quality of the developed formulas and helps to compare
between them.
• PI (Parametric Index): is calculated using the following formula:
PI ¼ nof parameterswithavalue  5=nof totalparameters ð5Þ
Where:
n˚ of parameters with a value5, indicates the number of parameters whose value is equal to
or higher than 5;
n˚ of total parameters indicates the total number of parameters studied;
Limit of acceptance:>0,5 and maximum value: 1
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The acceptability limit would correspond to: higher than 5 and maximum value of 10.
• GQI (Good Quality Index): calculated using the following formula:
GQI ¼ PPI  f ð7Þ
Limit of acceptance: higher than 5 and maximum value of 10.
f = Reliability factor = Polygon area/Circle area. In this case is 0.75.
The tool likewise provides us a graph of radius where it is possible to visualize easily the
properties of the formulation that has been developed (Fig 4).
A quality formula is considered to be one that occupies almost half of the graph’s area or, in
other words, one with a GQI of 5. This same tool can be used to evaluate the stability of the for-
mula: the same quality tests are applied after subjecting the formula to a stress process.
Fig 3. AQUALAB 4TEV equipment.
https://doi.org/10.1371/journal.pone.0201643.g003
Table 2. Conversion of results after centrifugation into radius values (r).
Results after centrifugation Radius value
With no phase separation at 5000 rpm/15 min r = 10
With no phase separation at 1000 rpm/15min r = 5
With phase separation at 1000 rpm/15 min r = 0
https://doi.org/10.1371/journal.pone.0201643.t002
Semi-solid Control Diagram (SSCD)
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Preparation of the different formulations
Given the characteristics of the active substance to formulate, it is decided to choose an oily
base with different coadjuvants.
Three formulations have been developed as shown in Table 4.
Different stability conditions have been applied and each condition has been evaluated by
the Semi-solid Control Diagram (SSCD):
Table 3. Conversion of limits of each parameter into radius values (r).
Parameter Limit value Conversion to radius
Organoleptic properties Homogeneity (P1) 0–2 eV = r = (P1 + P2 + P3 + P4 + P5)
Color (P2) 0–2
Flow through a tube or cannula (P3) 0–2
















Water activity 1–0 r = 10 − (10 × aw)
Centrifugation With no phase separation at 5000 rpm/15 min 10 r = 10
With no phase separation at 1000 rpm/15min 5 r = 5
With phase separation at 1000 rpm/ 15 min 0 r = 0
Note that the limit value of the parameters for viscosity and extensibility to be applied could be different depending on the quality target of the semisolid dosage form.
In this case the target required has been specified in brackets.
https://doi.org/10.1371/journal.pone.0201643.t003
Fig 4. Radius diagram obtained with the application of Semi-solid Control Diagram (SSCD).
https://doi.org/10.1371/journal.pone.0201643.g004
Semi-solid Control Diagram (SSCD)
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• Finished product controls: The Semi-solid Control Diagram (SSCD) is applied 24 hours
post manufacturing.
• Stress: There are no applicable regulations to define a stress conditions in semi-solid formu-
lations. In this case, the Semi-solid Control Diagram (SSCD) is applied after the submission
of the lipogel to different temperature changes as (internal laboratory conditions for stress
assays) it is explained as follows:
First step: 15 days at 30 ˚C (The sample is submitted to the Accelerated condition of Climate
Zone II)
Second step: 2 days at 5 ˚C (The sample is submitted to a low temperature).
Third step: 2 days at 22 ˚C (The sample is submitted to the Long Term Stability condition of
Climate Zone II)
Fourth step: Centrifugation at 1000 rpm during 15 minutes (The sample is submitted to a phys-
ical stress)
Fifth step: 2 days at 5 ˚C (The sample is submitted to a low temperature).
Sixth step: 3 days at 30 ˚C (The sample is submitted to the Accelerated condition of Climate
Zone II)
Seventh step: 2 days at 22 ˚C (The sample is submitted to the Long Term Stability condition of
Climate Zone II)
Lipogel preparation. The solid active substance is sieved through a 90 μm sieve. The
Medium-chain Triglycerides are heated until 80 ˚C with a heater plate. The Colloidal Silicon
Dioxide is added and the two components are mixed with mechanical stirring at 300 rpm. The
mechanical stirring is maintained until obtaining a homogeneous lipogel. The rest of compo-
nents are added and the lipogel is led to cool down.
Results and discussion
Semi-solid Control Diagram (SSCD) results for the three formulations
Formulation A1. Tables 5 and 6 show the Semi-solid Control Diagram results for Refer-
ence A1 for the finished product and Fig 5 shows the diagram obtained. (S1 Notebook)
The Parametric Index (PI = 0.6), the Parametric Profile Index (PPI = 5.7) and the Good
Quality Index (GQI = 5.1) show values that posit that the formulation has moderately accept-
able behaviour.
Table 4. Composition of Reference A1, A2 and A3.
Reference A1 Reference A2 Reference A3
Composition % % %
API 2.5 2.5 2.5
Colloidal Silicon Dioxide 6.0 6.0 6.0
Butylated Hydroxytoluene _ 0.1 _
Polysorbate 80 _ _ 2.0
Medium-chain Triglycerides Sufficient quantity per 100 Sufficient quantity per 100 Sufficient quantity per 100
https://doi.org/10.1371/journal.pone.0201643.t004
Semi-solid Control Diagram (SSCD)
PLOSONE | https://doi.org/10.1371/journal.pone.0201643 September 7, 2018 10 / 21
The values of both parameters “Organoleptic properties” (7.0) and “Viscosity” (9.2) are
higher than 5, which is more than acceptable with regard to the semi-solid formulation; it
meets the specifications required for the project, as far as the appearance (Fig 6). (S1 Appendix)
A value of 5.0 is obtained for “Centrifugation”, which is considered to be correct and suffi-
cient as far as the robustness of the formulation is concerned, but the value for “Water activity”
is 3.1, which means that this is a factor that needs to be taken into account in terms of the for-
mulation stability.
The value obtained in “Extensibility” is 4.1, which is slightly lower than the extensibility of
the reference standard. Nevertheless, it could be acceptable if all of the other parameters were
correct.
After subjecting the lipogel to stress conditions, variations have been observed in the values
of some of the radii of the parameters under study. The results of the finished product at time
zero and again after being subjected to stress conditions are shown in Table 5 and the compar-
ative diagram of both conditions in Fig 7.
Following the stress test, the Parametric Index (PI = 0.6), the Parametric Profile Index
(PPI = 5.3) and the Good Quality Index (GQI = 4.8) show values that are slightly lower than
those obtained for the finished product (Table 6).
The “Organoleptic properties” (7.0) and “Centrifugation” (5.0) parameters show the same
radius values as before the formulation underwent the stress test.
The “Viscosity” parameter has decreased considerably (5.4), but the values for the “Water
activity” (4.7) and “Extensibility” (4.4) parameters have increased somewhat due to the slight
loss of water from the formulation caused by the stress to which the sample was subjected.
In Fig 7 we can see that the orange area of the diagram, which corresponds to the stress con-
ditions, has decreased with respect to the finished product (blue area of the diagram), although
the difference is not very large (from 5.1 to 4.8).
Table 6. Index for the model.
Index for the model Finished product Stress conditions
PI (Parametric Index) 0.6 0.6
PPI (Parametric Profile Index) 5.7 5.3
GQI (Good Quality Index) 5.1 4.8
https://doi.org/10.1371/journal.pone.0201643.t006
Table 5. Semi-solid Control Diagram results for Reference A1 (Finished product and product subjected to stress conditions). The different values obtained from the
same assay have been marked in bold.
Parameters Limit value Experimental value RSD (%) Conversion to radius Radius value
Finished product Organoleptic properties (Corg) 0–10 7.0 _ eV = r = ∑ (C.org) 7.0
Viscosity (v) 10000 mPas
(from table1)
9234.3 3.20 r = 10-[(ν1-ν2)/1000] 9.2
Extensibility (ε) 1000 mm2 411.1 7.70 r = 10-(ε1/100-ε2/100) 4.1
Water activity (aw) 1–0 0.7 _ r = 10-(10aw) 3.1
Centrifugation (Cf) 0–10 5.0 _ 1000 rpm/15min = 5 5.0
Stress Conditions Organoleptic properties (Corg) 0–10 7.0 _ eV = r = ∑ (C.org) 7.0
Viscosity (v) 10000 mPas
(from table1)
5361.3 15.01 r = 10-[(ν1-ν2)/1000] 5.4
Extensibility (ε) 1000 mm2 444.4 5.91 r = 10-(ε1/100-ε2/100) 4.4
Water activity (aw) 1–0 0.5 _ r = 10-(10aw)) 4.7
Centrifugation (Cf) 0–10 5.0 _ 1000 rpm/15min = 5 5.0
https://doi.org/10.1371/journal.pone.0201643.t005
Semi-solid Control Diagram (SSCD)
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Fig 5. Semi-solid Control Diagram obtained for Reference A1.
https://doi.org/10.1371/journal.pone.0201643.g005
Fig 6. Appearance of Reference A1.
https://doi.org/10.1371/journal.pone.0201643.g006
Semi-solid Control Diagram (SSCD)
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Thus, it can be concluded that it is foreseeable that the formula will be physically stable, so
it could be a good candidate to continue the pharmaceutical development.
Formulation A2. Tables 7 and 8 show the Semi-solid Control Diagram results for Refer-
ence A2 and Fig 8 shows the diagram obtained. (S2 Notebook)
The Parametric Index (0.6), the Parametric Profile Index (5.6) and the Good Quality Index
(5.1) show values that posit that the formulation will have a moderately acceptable behaviour.
The parameters show values higher than or equal to 5 for “Organoleptic properties” (7.0),
“Viscosity” (7.3) and “Centrifugation” (5.0), which are very acceptable as far as the appearance
(Fig 9) and robustness of the semi-solid formulation is concerned.
For “Water activity” a value of 4.5 is obtained, which means that this is a factor that needs
to be accounted for in terms of the formulation stability. The value obtained for “Extensibility”
is 4.3, which is somewhat lower than the extensibility of the reference standard. (S2 Appendix)
After subjecting the lipogel to stress conditions variations have been observed in the values
of some of the radius of the parameters under study. The results of the finished product at time
zero and again after being subjected to stress conditions are shown in Table 6 and the compar-
ative diagram of both conditions in Fig 10.
Fig 7. Comparative diagram of Reference A1 (Finished product and product subjected to stress conditions).
https://doi.org/10.1371/journal.pone.0201643.g007
Table 7. Semi-solid Control Diagram results for Reference A2 (Finished product and product subjected to stress conditions). The different values obtained from the
same assay have been marked in bold.
Parameters Limit value Experimental value RSD (%) Conversion to radius Radius value
Finished product Organoleptic properties (Corg) 0–10 7.0 _ eV = r = ∑ (C.org) 7.0
Viscosity (v) 10000 mPas
(from table1)
7254.0 8.38 r = 10-[(ν1-ν2)/1000] 7.3
Extensibility (ε) 1000 mm2 433.5 7.78 r = 10-(ε1/100-ε2/100) 4.3
Water activity (aw) 1–0 0.6 _ r = 10-(10aw)) 4.5
Centrifugation (Cf) 0–10 5.0 _ 1000 rpm/15min = 5 5.0
Stress Conditions Organoleptic properties (Corg) 0–10 7.0 _ eV = r = ∑ (C.org) 7.0
Viscosity (v) 10000 mPas
(from table1)
4753.0 1.36 r = 10-[(ν1-ν2)/1000] 4.8
Extensibility (ε) 1000 mm2 501.7 5.44 r = 10-(ε1/100-ε2/100) 5.0
Water activity (aw) 1–0 0.4 _ r = 10-(10aw)) 5.9
Centrifugation (Cf) 0–10 5.0 _ 1000 rpm/15min = 5 5.0
https://doi.org/10.1371/journal.pone.0201643.t007
Semi-solid Control Diagram (SSCD)
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The Parametric Index (0.8), the Parametric Profile Index (5.5) and the Good Quality Index
(5.0) show values that are similar to those obtained for the finished product (Table 8).
The “Organoleptic properties” (7.0) and “Centrifugation” (5.0) parameters show the same
radius values as before the formulation underwent the stress test.
The “Viscosity” parameter has decreased considerably (4.8), but the “Water activity” (5.9)
and “Extensibility” (5.0) parameters have increased somewhat due to the slight loss of water
from the formulation caused by the stress to which the sample was subjected.
In Fig 10 we can see that orange area of the diagram, which corresponds to the stress condi-
tions, shows an area that is very similar to that of the finished product (blue area of the diagram).
Thus, it can be concluded that it is foreseeable that the formula will be physically stable.
Formulation A3. Show the Semi-solid Control Diagram results for Reference A3 and Fig
11 shows the diagram obtained. (S3 Notebook).
The Parametric Index (0.8), the Parametric Profile Index (5.0) and the Good Quality Index
(4.5) show values that are fairly low, that suggest that the formulation will possibly have an
unstable behaviour.
The parameters show values higher than or equal to 5 for “Organoleptic properties” (7.5),
“Viscosity” (6.4), “Centrifugation” (5.0) and Extensibility” (5.0), which are correct as far as the
appearance (Fig 12) and robustness of the semi-solid formulation.
Table 8. Index for the model.
Index for the model Finished product Stress conditions
PI (Parametric Index) 0.6 0.8
PPI (Parametric Profile Index) 5.6 5.5
GQI (Good Quality Index) 5.1 5.0
https://doi.org/10.1371/journal.pone.0201643.t008
Fig 8. Semi-solid Control Diagram obtained for Reference A2.
https://doi.org/10.1371/journal.pone.0201643.g008
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The value obtained for “Water activity” is 1.4, a very low value, which means that it is a fac-
tor that needs to be accounted for in terms of the formulation stability, as the formulation has
an elevated free or bound water content with high reactive capacity. (S3 Appendix)
After subjecting the lipogel to stress conditions, variations have been observed in the values
of some of the radii of the parameters under study. The results of the finished product at time
zero and again after being subjected to stress conditions are shown in Tables 9 and 10 and the
comparative diagram of both conditions in Fig 13.
The Parametric Index (0.8), the Parametric Profile Index (5.2) and the Good Quality Index
(4.6) show values that are similar to those obtained for the finished product.
The “Organoleptic properties” (7.5) and “Centrifugation” (5.0) parameters show the same
radius values as before the formulation underwent the stress test. The “Viscosity” parameter
has decreased considerably (5.2) but the “Water activity” (2.0) and “Extensibility” (6.0) param-
eters have increased somewhat due to the slight loss of water from the formulation caused by
the stress to which the sample was subjected.
Fig 9. Appearance of Reference A2.
https://doi.org/10.1371/journal.pone.0201643.g009
Semi-solid Control Diagram (SSCD)
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In Fig 13, it can be seen that the orange area of the diagram, which corresponds to the stress
conditions, shows an area that is very similar to that of the finished product (blue area of the
diagram).
Thus, it can be concluded that it is foreseeable that the formula will be not physically stable.
Verification of SSCD tool for a lipogel formulation
Individual comparisons of the results of the Parametric Index, the Parametric Profile Index
and the Good Quality Index of References A1, A2 and A3 before and after being subjected to
Fig 10. Comparative diagram of Reference A2 (Finished product and product subjected to stress conditions).
https://doi.org/10.1371/journal.pone.0201643.g010
Fig 11. Semi-solid Control Diagram obtained for Reference A3.
https://doi.org/10.1371/journal.pone.0201643.g011
Semi-solid Control Diagram (SSCD)
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stress conditions show that in every case there are variations in the index, so the Semi-solid
Control Diagram tool demonstrates its usefulness in the different stability tests for semi-solid
dosage forms.
Similarly, and as described above, this tool can be used to study what effect the addition
of certain excipients has on a base formulation and what effects such additions can have on
galenic controls.
Fig 12. Appearance of Reference A3.
https://doi.org/10.1371/journal.pone.0201643.g012
Table 9. Semi-solid Control Diagram results for Reference A3 (Finished product and Product). The different values obtained from the same assay have been marked
in bold.
Parameters Limit value Experimental value RSD (%) Conversion to radius Raddi value
Finished product Organoleptic properties (Corg) 0–10 7.5 _ eV = r = ∑ (C.org) 7.5
Viscosity (v) 10000 mPas
(from table1)
6357.8 3.07 r = 10-[(ν1-ν2)/1000] 6.4
Extensibility (ε) 1000 mm2 500.7 3.88 r = 10-(ε1/100-ε2/100) 5.0
Water activity (aw) 1–0 0.86 _ r = 10-(10aw)) 1.4
Centrifugation (Cf) 0–10 5.0 _ 1000 rpm/15min = 5 5.0
Stress Conditions Organoleptic properties (Corg) 0–10 7.5 _ eV = r = ∑ (C.org) 7.5
Viscosity (v) 10000 mPas
(from table1)
5214.0 11.90 r = 10-[(ν1-ν2)/1000] 5.2
Extensibility (ε) 1000 mm2 601.380 4.45 r = 10-(ε1/100-ε2/100) 6.0
Water activity (aw) 1–0 0.79 _ r = 10-(10aw)) 2.0
Centrifugation (Cf) 0–10 5.0 _ 1000 rpm/15min = 5 5.0
https://doi.org/10.1371/journal.pone.0201643.t009
Semi-solid Control Diagram (SSCD)
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From a comparison of the three references that were manufactured, it could be concluded
that the addition of butylhydroxytoluene in Reference A2 does not modify its Good Quality
Index, so it may be considered that adding it will have no impact insofar as galenic controls are
concerned.
The addition of Tween1 80 in Reference 3 does indeed involve a more marked decrease of
the Good Quality Index, going from an acceptable value to one that is poor (4.5). This could
affect the stability of the formulation, so a benefit/risk assessment of adding this excipient
should be made.
On the one hand, two of the studied parameters, Viscosity and Extensibility, usually present
a wide range of results due to the nature of the assay so it is often difficult to observe significant
differences between formulations taking into account these two parameters.
On the other hand, SSCD, by having the ability to evaluate the five parameters together,
allows to obtain three different indexes that help us to detect differences between formulations
or between excipients that would be difficult or impossible to detect analysing the parameters
individually.
These differences help the formulator to discriminate and optimize the process of pharma-
ceutical development.
To demonstrate improvement in the pharmaceutical development of semisolid pharmaceu-
tical forms and the application of SSCD tool, in Tables 11 and 12 different formulations are
compared.
For example, fixing us the parameter of viscosity in Table 11, the three values obtained for
the three formulations are among 40000 and 5000 mPas. In galenical terms, these results are
the same but these small differences are reflected in the Good Quality Index.
Table 10. Index for the model.
Index for the model Finished product Stress conditions
PI (Parametric Index) 0.8 0.8
PPI (Parametric Profile Index) 5.0 5.2
GQI (Good Quality Index) 4.5 4.6
https://doi.org/10.1371/journal.pone.0201643.t010
Fig 13. Comparative diagram of Reference A3 (Finished product and product subjected to stress conditions).
https://doi.org/10.1371/journal.pone.0201643.g013
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Therefore, the differences detected between the GQI value of references A1 and A3 (a dif-
ference of 0.6) would not have been perceived if the individual parameters had been analysed.
SCDD has allowed to discard the use of one excipient (Tween 80 in Reference A3) since its
affects the quality of the formulation. The addition of butylhydroxytoluene in Reference A2
does not affect the quality of the reference so the addition of this would be evaluated by the
formulator.
Seeing the stability data of the three references subjected to stress conditions and taking
into account the GQI, the Reference A2 can be considered the best formulation. (Table 12)
So, analyzing all the data obtained with SSCD, the development line should be followed
from Reference A2 since it has obtained the best indexes of both, finished product and product
subjected to stress conditions.
In this way, it is avoided to go ahead with two formulations that do not bring the expected
quality to the development.
This tool allows the detection of the quality differences, which indirectly reduces the num-
ber of trials to be performed and optimize the costs of the pharmaceutical development.
Conclusions
From the results obtained from the development of this experimental project, it is concluded
that:
1. The Semi-solid Control Diagram (SSCD) could be an excellent tool for the galenic charac-
terization of semi-solid pharmaceutical dosage forms as SeDeM is for solid pharmaceutical
dosage forms.
Table 12. Semi-solid Control Diagram results for References A1, A2 and A3 (Product subjected to stress conditions).
Galenical Parameters usually evaluated Reference A1 Reference A2 Reference A3
Organoleptic properties (Corg) 7.0 7.0 7.5
Viscosity (mPas) 5361.3 4753.0 5214.0
Extensibility (mm2) 444.4 501.7 601.4
Water activity 0.5 0.4 0.8
Centrifugation 5.0 5.0 5.0
Index for the model
PI (Parametric Index) 0.6 0.8 0.8
PPI (Parametric Profile Index) 5.3 5.5 5.2
GQI (Good Quality Index) 4.8 5.0 4.6
https://doi.org/10.1371/journal.pone.0201643.t012
Table 11. Semi-solid Control Diagram results for References A1, A2 and A3 (Finished product).
Galenical Parameters usually evaluated Reference A1 Reference A2 Reference A3
Organoleptic properties (Corg) 7.0 7.0 7.5
Viscosity (mPas) 9234.3 7254.0 6357.8
Extensibility (mm2) 411.1 433.5 500.7
Water activity 0.7 0.6 0.9
Centrifugation 5.0 5.0 5.0
Index for the model SSCD
PI (Parametric Index) 0.6 0.6 0.8
PPI (Parametric Profile Index) 5.7 5.6 5.0
GQI (Good Quality Index) 5.1 5.1 4.5
https://doi.org/10.1371/journal.pone.0201643.t011
Semi-solid Control Diagram (SSCD)
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2. The Semi-solid Control Diagram (SSCD) is of great use for formulation studies since it
allows the effect of adding different excipients to a base semi-solid formulation to be stud-
ied, as well as, it is useful to know the performance of comparative studies of the same
excipient from different suppliers.
3. This tool can also be used to perform and track stability studies of semi-solid formulation,
as it allows to compare the diagrams made under different conditions and times and their
impact on the formulation to be assessed.
Therefore, the SSCD tool is proposed as an adequate tool for the physicochemical control
of semisolid pharmaceutical forms. In this article the tool has been described and its suitability
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Validation: Pilar Pérez-Lozano, Encarna Garcı́a-Montoya.
Writing – original draft: Anna Nardi-Ricart.
Writing – review & editing: Lara Bachs-deMiquel.
Semi-solid Control Diagram (SSCD)
PLOSONE | https://doi.org/10.1371/journal.pone.0201643 September 7, 2018 20 / 21
References
1. Faulı́ C. Tratado de Farmacia Galénica. 1st ed. Madrid: Luzán 5, S.A;1993
2. Fahr A. Voigt’s Pharmaceutical Technology. 1st ed in English. Wiley; 2018.
3. Bora A., Deshmukh S., Swain K. Recent advances in semisolid dosage forms. Int J Pharm Sci Res.
2014. 5(9):3594–3608.
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